BioStar Ventures III, L.P. - Jun 18, 2024 Form 4 Insider Report for Autonomix Medical, Inc. (AMIX)

Role: 10%+ Owner
Signature: BioStar Ventures III, L.P. By: BioStar Ventures III, L.L.C. Its: General Partner /s/ Louis Cannon, MD Name: Louis Cannon, MD Title: Founder, Senior Managing Director
Stock symbol: AMIX
Transactions as of: Jun 18, 2024
Transactions value $: $30,464
Form type: 4
Date filed: 6/20/2024, 08:23 PM
Previous filing: Feb 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMIX	Warrant to Purchase Common Stock	Purchase	$30.5K	+1.09M		$0.03^*	1.09M	Jun 18, 2024	Common Stock	1.09M	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The ability of the Reporting Person to exercise the warrants is subject to a beneficial ownership limitation initially set at 4.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of common stock issuable upon exercise of the warrants. This beneficial ownership limitation may be increased or decreased at the election of the holder, provided that the beneficial ownership limitation in no event exceeds 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock upon exercise of the warrants and any increase shall not be effective until the 61st day after notice of adjustment is provided to the Issuer.

Content

The ability of the Reporting Person to exercise the warrants is subject to a beneficial ownership limitation initially set at 4.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of common stock issuable upon exercise of the warrants. This beneficial ownership limitation may be increased or decreased at the election of the holder, provided that the beneficial ownership limitation in no event exceeds 9.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock upon exercise of the warrants and any increase shall not be effective until the 61st day after notice of adjustment is provided to the Issuer.